Eli Lilly aims to expand its global footprint by introducing its blockbuster drug, Mounjaro, to major markets such as China, India, Brazil, and Mexico by 2026, according to Chief Financial Officer Lucas Montarce.
About the Author
Eli Lilly aims to expand its global footprint by introducing its blockbuster drug, Mounjaro, to major markets such as China, India, Brazil, and Mexico by 2026, according to Chief Financial Officer Lucas Montarce.
